Nathaniel Steele
Family · Edinburg, TXNPI 1417433772
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.5% of the total across 154 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 31 manufacturers, the largest accounting for just 17.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,390 and has fallen 96.1% since, to $55 in 2025.
Across 154 payments — averaging $17.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$462
- Amgen$407
- AbbVie$303
- Dexcom, Inc.$144
- Amarin Pharma, Inc.$144
- Merck$123
- plus $1K from 25 others
What the payments were for
- Food & beverage$2,63099%
- Education$141%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 21 | $462 |
| Amgen(2 entities) | 16 | $407 |
| AbbVie | 25 | $303 |
| Dexcom, Inc. | 8 | $144 |
| Amarin Pharma, Inc. | 10 | $144 |
| Merck | 8 | $123 |
| Boehringer Ingelheim | 7 | $98 |
| Lilly USA, LLC | 6 | $93 |
| AstraZeneca | 5 | $77 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $75 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $72 |
| Astellas Pharma US Inc | 4 | $68 |
| Sanofi Pasteur Inc. | 3 | $59 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $49 |
| Genentech USA, Inc. | 3 | $41 |
| Antares Pharma, Inc. | 3 | $41 |
| Sanofi-aventis U.S. LLC | 2 | $38 |
| Biohaven Pharmaceuticals, Inc. | 2 | $36 |
| Kowa Pharmaceuticals America, Inc. | 2 | $35 |
| GSK | 2 | $35 |
| Ironwood Pharmaceuticals, Inc | 2 | $35 |
| Eisai Inc. | 2 | $33 |
| Mylan Specialty L.p. | 2 | $31 |
| Redhill Biopharma Inc. | 2 | $30 |
| Seqirus USA Inc | 1 | $23 |
| Pfizer | 1 | $19 |
| Otsuka America Pharmaceutical, Inc. | 1 | $15 |
| Novartis | 1 | $15 |
| Cumberland Pharmaceuticals, Inc. | 1 | $14 |
| Biogen | 1 | $13 |
| Arbor Pharmaceuticals, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,644 in reported general payments places this provider in the 85th percentile of 15,456 family providers in Texas.
Other family in Edinburg
- Mayra CantazaroEdinburg$150K
- David WeirDallas$959K
- Robin BeachHouston$428K
- April LopezMcAllen$417K
- Sarah AguilarHouston$199K
- Sie ThomasDallas$197K
- Anna CastroSan Antonio$184K
- Jill CampbellShenandoah$182K
- Angela AchaPflugerville$174K
- Susan BowlinIrving$164K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.